Risk of malignant disease in 1-year sepsis survivors, a registry-based nationwide follow-up study.

"Declarations Ethic approval and consent to participateThe study protocol was approved by the Regional ethical board of Uppsala, Sweden (October 12, 2016, Dnr 2016/421 and 2016-421-1). Due to the retrospective registry study design, the need for informed consent was waived. Consent for publicationNot applicable. Competing interestsAB, GS and ML declare no conflicts of interest. JH has a leadership role in the Finnish Sepsis society and has received reimbursements for advisory board work (PAION). Competing interests AB, GS and ML declare no conflicts of interest. JH has a leadership role in the Finnish Sepsis society and has received reimbursements for advisory board work (PAION)."

"Funding Open access funding provided by Tampere University (including Tampere University Hospital). Funding was provided by the Uppsala University Hospital Research Fund (ML)."